Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$239.25 - $280.76 $1.12 Million - $1.32 Million
-4,700 Reduced 61.04%
3,000 $834 Million
Q2 2024

Aug 05, 2024

BUY
$235.51 - $267.98 $164,857 - $187,586
700 Added 10.0%
7,700 $1.92 Billion
Q1 2024

Apr 29, 2024

BUY
$224.58 - $256.19 $1.12 Million - $1.28 Million
5,000 Added 250.0%
7,000 $1.75 Billion
Q4 2023

Jan 24, 2024

BUY
$185.1 - $233.13 $148,080 - $186,504
800 Added 66.67%
2,000 $463 Million
Q3 2023

Nov 01, 2023

BUY
$233.08 - $265.59 $279,696 - $318,707
1,200 New
1,200 $298 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $173B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Xy Capital LTD Portfolio

Follow Xy Capital LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xy Capital LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xy Capital LTD with notifications on news.